...
首页> 外文期刊>Chemistry & biology >MCAT is not required for in vitro polyketide synthesis in a minimal actinorhodin polyketide synthase from Streptomyces coelicolor
【24h】

MCAT is not required for in vitro polyketide synthesis in a minimal actinorhodin polyketide synthase from Streptomyces coelicolor

机译:最小的放线链霉菌放线菌素聚酮化合物合酶中的体外聚酮化合物合成不需要MCAT

获取原文
获取原文并翻译 | 示例

摘要

Background: It has been proposed that Streptomyces malonyl CoA:holo acyl carrier protein transacylases (MCATs) provide a link between fatty acid and polyketide biosynthesis. Two recent studies have provided evidence that the presence of MCAT is essential for polyketide synthesis to proceed in reconstituted minimal polyketide synthases (PKSs). In contrast to this, we previously showed that the hole acyl carrier proteins (ACPs) from type II PKSs are capable of catalytic self-malonylation in the presence of malonyl CoA, which suggests that MCAT might not be necessary for polyketide biosynthesis. Results: We reconstituted a homologous actinorhodin (act) type II minimal PKS in vitro, When act holo-ACP is present in limiting concentrations, MCAT is required by the synthase complex in order for polyketide biosynthesis to proceed, When holo-ACP is present in excess, however, efficient polyketide synthesis proceeds without MCAT. The rate of polyketide production increases with holo-ACP concentration, but at low ACP concentration or equimolar ACP:KS:CLF (KS, ketosynthase; CLF, chain length determining factor) concentrations this rate is significantly lower than expected, indicating that free holo-ACP is sequestered by the KS/CLF complex. Conclusions: The rate of polyketide biosynthesis is dictated by the ratio of holo-ACP to KS and CLF, as well as by the total protein concentration. There is no absolute requirement for MCAT in polyketide biosynthesis in vitro, although the role of MCAT during polyketide synthesis in vivo remains an open question. MCAT might be responsible for the rate enhancement of malonyl transfer at very low free holo-ACP concentrations or it could be required to catalyse the transfer of malonyl groups from malonyl CoA to sequestered holo-ACP. [References: 36]
机译:背景:已提出链霉菌丙二酰辅酶A:全酰基载体蛋白转酰基转移酶(MCAT)提供了脂肪酸与聚酮化合物生物合成之间的联系。最近的两项研究提供了证据,表明MCAT的存在对于在重构的最小聚酮化合物合酶(PKSs)中进行聚酮化合物合成至关重要。与此相反,我们先前显示,在丙二酰辅酶A存在下,来自II型PKS的孔酰基载体蛋白(ACP)能够催化自身丙二酰化反应,这表明MCAT对于聚酮化合物的生物合成可能不是必需的。结果:我们在体外重建了同源的II型肌动蛋白(act)最小PKS,当act holo-ACP以极限浓度存在时,合酶复合物需要MCAT才能进行聚酮化合物的生物合成,而在holo-ACP存在时但是,如果没有过量的聚酮化合物,则无需MCAT即可进行有效的合成。聚酮化合物的生成速率随全ACP浓度的增加而增加,但在低ACP浓度或等摩尔ACP:KS:CLF(KS,酮合成酶; CLF,链长决定因子)浓度下,该速率显着低于预期,表明游离全ACP KS / CLF复合体隔离了ACP。结论:聚酮化合物的生物合成速率取决于完整的ACP与KS和CLF的比例,以及总蛋白浓度。尽管MCAT在体内聚酮化合物合成过程中的作用仍然是一个悬而未决的问题,但在体外聚酮化合物的生物合成中对MCAT并没有绝对的要求。 MCAT可能负责在非常低的游离全环ACP浓度下丙二酰转移速率的提高,或者可能需要催化丙二酰基从丙二酸CoA到螯合的全ACP的转移。 [参考:36]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号